 Angela Pierce
Concepts (197)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebellar Neoplasms | 7 | 2025 | 177 | 1.190 |
Why?
| | Medulloblastoma | 7 | 2025 | 215 | 1.170 |
Why?
| | Receptor Protein-Tyrosine Kinases | 5 | 2016 | 230 | 1.080 |
Why?
| | Brain Neoplasms | 7 | 2025 | 1327 | 0.860 |
Why?
| | Infratentorial Neoplasms | 2 | 2024 | 71 | 0.770 |
Why?
| | Ependymoma | 2 | 2024 | 176 | 0.700 |
Why?
| | Gene Expression Regulation, Neoplastic | 9 | 2025 | 1462 | 0.660 |
Why?
| | Proto-Oncogene Proteins c-myc | 5 | 2025 | 167 | 0.630 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2019 | 79 | 0.600 |
Why?
| | Glioblastoma | 4 | 2016 | 354 | 0.590 |
Why?
| | Glioma | 5 | 2025 | 427 | 0.580 |
Why?
| | Reproduction | 2 | 2011 | 207 | 0.550 |
Why?
| | Chemoradiotherapy | 1 | 2019 | 239 | 0.540 |
Why?
| | Proto-Oncogene Proteins | 6 | 2022 | 624 | 0.540 |
Why?
| | Rhabdoid Tumor | 3 | 2025 | 103 | 0.490 |
Why?
| | Cell Line, Tumor | 17 | 2025 | 3560 | 0.460 |
Why?
| | Protein-Tyrosine Kinases | 2 | 2020 | 433 | 0.440 |
Why?
| | Transplantation, Heterologous | 1 | 2014 | 194 | 0.410 |
Why?
| | Neoplasm Transplantation | 1 | 2014 | 252 | 0.410 |
Why?
| | SMARCB1 Protein | 2 | 2025 | 34 | 0.360 |
Why?
| | Carcinogenesis | 1 | 2013 | 229 | 0.350 |
Why?
| | Xenograft Model Antitumor Assays | 7 | 2025 | 931 | 0.350 |
Why?
| | Central Nervous System | 1 | 2013 | 281 | 0.340 |
Why?
| | Estrous Cycle | 1 | 2011 | 23 | 0.330 |
Why?
| | Gonadotropin-Releasing Hormone | 2 | 2011 | 212 | 0.320 |
Why?
| | Pituitary Gland | 1 | 2011 | 148 | 0.320 |
Why?
| | Hypothalamus | 1 | 2011 | 160 | 0.310 |
Why?
| | Mice | 18 | 2025 | 18394 | 0.300 |
Why?
| | Ovary | 1 | 2011 | 228 | 0.300 |
Why?
| | Disease Models, Animal | 1 | 2019 | 4580 | 0.290 |
Why?
| | Cell Cycle Proteins | 3 | 2022 | 630 | 0.280 |
Why?
| | Oncogene Proteins | 1 | 2008 | 61 | 0.280 |
Why?
| | Apoptosis | 7 | 2025 | 2430 | 0.270 |
Why?
| | Cell Proliferation | 8 | 2025 | 2506 | 0.260 |
Why?
| | Neurons | 3 | 2014 | 1642 | 0.250 |
Why?
| | Animals | 21 | 2025 | 38177 | 0.240 |
Why?
| | 12E7 Antigen | 1 | 2025 | 10 | 0.230 |
Why?
| | Cyclin-Dependent Kinase 8 | 1 | 2025 | 50 | 0.230 |
Why?
| | Radiation Tolerance | 2 | 2025 | 103 | 0.220 |
Why?
| | Sirtuin 2 | 1 | 2025 | 27 | 0.220 |
Why?
| | Transcription, Genetic | 3 | 2025 | 1496 | 0.210 |
Why?
| | Positive Transcriptional Elongation Factor B | 1 | 2024 | 29 | 0.210 |
Why?
| | Epigenesis, Genetic | 2 | 2025 | 687 | 0.190 |
Why?
| | Protein Biosynthesis | 1 | 2025 | 458 | 0.190 |
Why?
| | Antineoplastic Agents | 4 | 2022 | 2202 | 0.190 |
Why?
| | Tumor Cells, Cultured | 2 | 2025 | 920 | 0.190 |
Why?
| | DNA Repair | 2 | 2024 | 256 | 0.180 |
Why?
| | Intercellular Signaling Peptides and Proteins | 3 | 2016 | 381 | 0.180 |
Why?
| | CDC2 Protein Kinase | 1 | 2002 | 27 | 0.180 |
Why?
| | DNA, Fungal | 1 | 2002 | 83 | 0.180 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 1 | 2022 | 67 | 0.170 |
Why?
| | Teratoma | 2 | 2022 | 124 | 0.170 |
Why?
| | DNA Replication | 1 | 2002 | 252 | 0.160 |
Why?
| | Polycomb Repressive Complex 1 | 1 | 2020 | 66 | 0.160 |
Why?
| | Genes, myc | 1 | 2020 | 51 | 0.160 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2025 | 886 | 0.160 |
Why?
| | Transcriptional Elongation Factors | 1 | 2020 | 39 | 0.150 |
Why?
| | Pyrazoles | 2 | 2022 | 510 | 0.150 |
Why?
| | Mice, Nude | 3 | 2019 | 688 | 0.150 |
Why?
| | Pyrimidinones | 1 | 2020 | 126 | 0.150 |
Why?
| | Mice, SCID | 1 | 2019 | 369 | 0.140 |
Why?
| | Protein Kinase Inhibitors | 2 | 2016 | 974 | 0.140 |
Why?
| | Deoxycytidine | 1 | 2020 | 221 | 0.140 |
Why?
| | c-Mer Tyrosine Kinase | 3 | 2016 | 38 | 0.140 |
Why?
| | Piperazines | 2 | 2022 | 381 | 0.140 |
Why?
| | DNA-Binding Proteins | 2 | 2004 | 1503 | 0.140 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2002 | 419 | 0.140 |
Why?
| | Antibodies, Monoclonal | 1 | 2025 | 1525 | 0.130 |
Why?
| | Mice, Inbred NOD | 1 | 2019 | 610 | 0.130 |
Why?
| | Cellular Senescence | 2 | 2019 | 228 | 0.130 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2022 | 533 | 0.130 |
Why?
| | Histones | 2 | 2020 | 673 | 0.130 |
Why?
| | Saccharomyces cerevisiae | 1 | 2002 | 579 | 0.130 |
Why?
| | Chromatin | 4 | 2025 | 561 | 0.130 |
Why?
| | Polyploidy | 1 | 2016 | 15 | 0.130 |
Why?
| | Humans | 23 | 2025 | 145305 | 0.120 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2019 | 339 | 0.120 |
Why?
| | Cell Death | 1 | 2016 | 383 | 0.110 |
Why?
| | Mice, Knockout | 3 | 2014 | 3127 | 0.110 |
Why?
| | Pentacyclic Triterpenes | 1 | 2014 | 12 | 0.110 |
Why?
| | Survival Rate | 1 | 2019 | 2100 | 0.110 |
Why?
| | Sexual Maturation | 1 | 2014 | 51 | 0.100 |
Why?
| | Nuclear Proteins | 3 | 2023 | 750 | 0.100 |
Why?
| | CRISPR-Cas Systems | 2 | 2025 | 170 | 0.100 |
Why?
| | Adenine | 1 | 2016 | 339 | 0.100 |
Why?
| | Anilides | 1 | 2014 | 84 | 0.100 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2014 | 120 | 0.100 |
Why?
| | Quinolines | 1 | 2014 | 193 | 0.090 |
Why?
| | Vagina | 1 | 2014 | 201 | 0.090 |
Why?
| | Cell Movement | 3 | 2014 | 965 | 0.090 |
Why?
| | Superovulation | 1 | 2011 | 8 | 0.090 |
Why?
| | RNA Polymerase II | 2 | 2025 | 351 | 0.090 |
Why?
| | Cholesterol Side-Chain Cleavage Enzyme | 1 | 2011 | 9 | 0.090 |
Why?
| | Mice, 129 Strain | 1 | 2011 | 86 | 0.080 |
Why?
| | Child | 5 | 2024 | 22712 | 0.080 |
Why?
| | Chorionic Gonadotropin | 1 | 2011 | 77 | 0.080 |
Why?
| | Feedback, Physiological | 1 | 2011 | 83 | 0.080 |
Why?
| | RNA, Small Interfering | 2 | 2014 | 635 | 0.080 |
Why?
| | Luteinizing Hormone | 1 | 2011 | 190 | 0.080 |
Why?
| | Ovariectomy | 1 | 2011 | 162 | 0.080 |
Why?
| | Cell Cycle | 2 | 2004 | 600 | 0.080 |
Why?
| | Epigenomics | 2 | 2020 | 114 | 0.080 |
Why?
| | Cell Survival | 2 | 2014 | 1099 | 0.080 |
Why?
| | Follicle Stimulating Hormone | 1 | 2011 | 249 | 0.080 |
Why?
| | Periodontal Ligament | 1 | 2009 | 3 | 0.080 |
Why?
| | Tooth Movement Techniques | 1 | 2009 | 13 | 0.080 |
Why?
| | Aging | 1 | 2020 | 1968 | 0.080 |
Why?
| | Receptors, Nerve Growth Factor | 1 | 2009 | 18 | 0.070 |
Why?
| | Nerve Growth Factor | 1 | 2009 | 34 | 0.070 |
Why?
| | Female | 9 | 2025 | 78605 | 0.070 |
Why?
| | Estrus | 1 | 2008 | 16 | 0.070 |
Why?
| | Mice, Inbred C57BL | 2 | 2011 | 6007 | 0.070 |
Why?
| | Prosencephalon | 1 | 2008 | 53 | 0.070 |
Why?
| | DNA Primers | 1 | 2008 | 512 | 0.070 |
Why?
| | Protein Multimerization | 1 | 2008 | 214 | 0.060 |
Why?
| | Models, Neurological | 1 | 2008 | 254 | 0.060 |
Why?
| | Cyclin-Dependent Kinase 9 | 1 | 2025 | 18 | 0.060 |
Why?
| | Isocitrate Dehydrogenase | 1 | 2025 | 71 | 0.060 |
Why?
| | Nerve Net | 1 | 2008 | 285 | 0.060 |
Why?
| | Cell Differentiation | 2 | 2025 | 2053 | 0.060 |
Why?
| | Base Sequence | 1 | 2008 | 2191 | 0.050 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2022 | 1148 | 0.050 |
Why?
| | Chromosomes | 1 | 2024 | 108 | 0.050 |
Why?
| | Signal Transduction | 2 | 2014 | 5239 | 0.050 |
Why?
| | Fluorouracil | 1 | 2024 | 235 | 0.050 |
Why?
| | Tyrosine | 1 | 2023 | 222 | 0.050 |
Why?
| | Cell Line | 1 | 2008 | 2882 | 0.050 |
Why?
| | Cyclin B | 1 | 2002 | 16 | 0.050 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2023 | 168 | 0.050 |
Why?
| | Replication Origin | 1 | 2002 | 21 | 0.050 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2025 | 451 | 0.050 |
Why?
| | Single-Cell Analysis | 1 | 2025 | 359 | 0.050 |
Why?
| | G2 Phase Cell Cycle Checkpoints | 1 | 2022 | 44 | 0.050 |
Why?
| | G1 Phase | 1 | 2002 | 66 | 0.040 |
Why?
| | S Phase | 1 | 2002 | 80 | 0.040 |
Why?
| | Radiation, Ionizing | 1 | 2022 | 87 | 0.040 |
Why?
| | Mutation | 2 | 2025 | 4104 | 0.040 |
Why?
| | Gene Expression Regulation, Fungal | 1 | 2002 | 78 | 0.040 |
Why?
| | Nicotine | 1 | 2004 | 332 | 0.040 |
Why?
| | Schizosaccharomyces pombe Proteins | 1 | 2002 | 76 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2022 | 241 | 0.040 |
Why?
| | Male | 5 | 2020 | 72628 | 0.040 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2023 | 460 | 0.040 |
Why?
| | Quinazolines | 1 | 2022 | 266 | 0.040 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2022 | 280 | 0.040 |
Why?
| | Brain Stem Neoplasms | 1 | 2020 | 87 | 0.040 |
Why?
| | Astrocytoma | 1 | 2020 | 129 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2022 | 622 | 0.040 |
Why?
| | Cell Self Renewal | 1 | 2019 | 53 | 0.040 |
Why?
| | Azepines | 1 | 2019 | 107 | 0.030 |
Why?
| | Lysine | 1 | 2020 | 302 | 0.030 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2019 | 142 | 0.030 |
Why?
| | Sulfonamides | 1 | 2022 | 581 | 0.030 |
Why?
| | Carrier Proteins | 1 | 2002 | 739 | 0.030 |
Why?
| | Immunohistochemistry | 2 | 2014 | 1718 | 0.030 |
Why?
| | Triazoles | 1 | 2019 | 184 | 0.030 |
Why?
| | Enzyme Inhibitors | 1 | 2020 | 826 | 0.030 |
Why?
| | Transcription Factors | 1 | 2004 | 1746 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2004 | 1984 | 0.030 |
Why?
| | Pregnancy | 1 | 2008 | 7208 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2016 | 768 | 0.030 |
Why?
| | Neural Stem Cells | 1 | 2016 | 166 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2020 | 2192 | 0.030 |
Why?
| | Dacarbazine | 1 | 2014 | 100 | 0.030 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2014 | 187 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2014 | 341 | 0.020 |
Why?
| | Tumor Burden | 1 | 2014 | 323 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2014 | 173 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2014 | 510 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2014 | 437 | 0.020 |
Why?
| | Colorado | 1 | 2022 | 4579 | 0.020 |
Why?
| | Alveolar Process | 1 | 2009 | 6 | 0.020 |
Why?
| | Dental Pulp | 1 | 2009 | 4 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2014 | 2032 | 0.020 |
Why?
| | Orthodontic Appliances | 1 | 2009 | 13 | 0.020 |
Why?
| | Tooth Root | 1 | 2009 | 21 | 0.020 |
Why?
| | Phosphorylation | 1 | 2014 | 1735 | 0.020 |
Why?
| | Receptor, trkA | 1 | 2009 | 18 | 0.020 |
Why?
| | Receptors, Growth Factor | 1 | 2009 | 56 | 0.020 |
Why?
| | Calcitonin Gene-Related Peptide | 1 | 2009 | 40 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2024 | 11731 | 0.020 |
Why?
| | Nerve Fibers | 1 | 2009 | 104 | 0.020 |
Why?
| | Random Allocation | 1 | 2009 | 363 | 0.020 |
Why?
| | Prognosis | 1 | 2016 | 4310 | 0.020 |
Why?
| | Brain | 1 | 2020 | 2945 | 0.020 |
Why?
| | Nerve Tissue Proteins | 1 | 2009 | 593 | 0.010 |
Why?
| | Child, Preschool | 1 | 2020 | 11863 | 0.010 |
Why?
| | Cyclin-Dependent Kinase 4 | 1 | 2004 | 53 | 0.010 |
Why?
| | NFATC Transcription Factors | 1 | 2004 | 93 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2009 | 2541 | 0.010 |
Why?
| | Cyclin-Dependent Kinases | 1 | 2004 | 123 | 0.010 |
Why?
| | Rats | 1 | 2009 | 5616 | 0.010 |
Why?
| | Calcium | 1 | 2004 | 1185 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2004 | 4155 | 0.010 |
Why?
| | Cytokines | 1 | 2004 | 2066 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2004 | 2833 | 0.010 |
Why?
| | Phenotype | 1 | 2004 | 3172 | 0.010 |
Why?
|
|
Pierce's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|